Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 9-Hexadecenoic acid, 1,1'-[(9,10-dihydro-5,8-dihydroxy-9,10-dioxo-1,4-anthracenediyl)bis(imino-2,1-ethanediy... | 1349197-90-5 | 98.37% | 917.27 | 25 MG
SDP

Catalog No. 5000363424
Encompass_Preferred

di-Pal-MTO is a palm oil-based lipid created by combining the anticancer agent mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they effectively deliver siRNA to cells and enhance anticancer activity.

  • Effective siRNA cell delivery
  • Enhances anticancer activity
  • Reduces tumor cell viability by 81% in vitro
  • Reduces tumor size by 83% in vitro

Catalog No. 50-003-63424 Supplier Medchemexpress LLC Supplier No. 25MGHY148702
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

di-Pal-MTO is a palm oil-based lipid created by combining the anticancer agent mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they effectively deliver siRNA to cells and enhance anticancer activity.

  • Effective siRNA cell delivery
  • Enhances anticancer activity
  • Reduces tumor cell viability by 81% in vitro
  • Reduces tumor size by 83% in vitro

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.